OrbiMed

Sep 18, 2025

Biovance Capital leads Series A Financing in Mondego Bio together with OrbiMed and Torrey Pines

Aug 04, 2025

OrbiMed Raises $1.86 Billion for Healthcare Royalty & Credit Fund V

Nov 14, 2024

NEURELIS ENTERS $208 MILLION AGREEMENT TO MONETIZE INTRAVAIL ROYALTIES

Jul 30, 2020

i2020 Accelerator of Torrey Pines Investment in Breakthrough Cancer Programs together with OrbiMed

May 27, 2020

Q32 Bio Launches to Develop Novel Therapeutics Targeting Regulators of Innate and Adaptive Immunity

Apr 01, 2020

Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease